Drug prices aren’t a big problem, but Ottawa’s trying to control the market anyway.
Brett Skinner | Financial Post | Feb 28, 2019
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
